Crossmark

Management of Dermatological Adverse Events Associated With MEK Inhibitors

Crossref DOI link: https://doi.org/10.1016/j.ad.2026.104664

Published Print: 2026-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Prat, C.

Berbegal de Gracia, L.

Bernabeu-Wittel, J.

Campos Domínguez, M.

Évole, M.

Feito-Rodríguez, M.

Gilaberte, Y.

Martín-Santiago, A.

Rosario González-Hermosa, M.

Monserrat-García, M.T.

Palencia Pérez, S.I.

Vicente, A.

del Pozo Losada, J.
Funding

Funding for this research was provided by:

Universitat de Barcelona

AstraZeneca
License Information

Text and Data Mining valid from 2026-09-01

Text and Data Mining valid from 2026-09-01

Version of Record valid from 2026-04-15
More Information

This article is maintained by: Elsevier

Article Title: Management of Dermatological Adverse Events Associated With MEK Inhibitors

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2026.104664

Content Type: article

Copyright: © 2026 AEDV. Published by Elsevier España, S.L.U.